Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities
Rheumatoid arthritis (RA) is a common autoimmune disease worldwide. Neutrophils play critical roles in the onset and development of RA and are the promising target for RA treatment. Tetrandrine is a bis-benzyl isoquinoline alkaloid derived from the traditional Chinese herbal Stephania tetrandra S. M...
Gespeichert in:
| Veröffentlicht in: | Evidence-based complementary and alternative medicine 2022, Vol.2022, p.8589121-13 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 13 |
|---|---|
| container_issue | |
| container_start_page | 8589121 |
| container_title | Evidence-based complementary and alternative medicine |
| container_volume | 2022 |
| creator | Lu, Qingyi Jiang, Haixu Zhu, Qingqing Xu, Jie Cai, Yanan Huo, Guiyang Yuan, Kai Huang, Guangrui Xu, Anlong |
| description | Rheumatoid arthritis (RA) is a common autoimmune disease worldwide. Neutrophils play critical roles in the onset and development of RA and are the promising target for RA treatment. Tetrandrine is a bis-benzyl isoquinoline alkaloid derived from the traditional Chinese herbal Stephania tetrandra S. Moore. Tetrandrine is effective in alleviating RA by inhibiting macrophage inflammatory response, fibroblast overproliferation, and pannus formation. However, whether tetrandrine regulates the activities of neutrophils in RA is largely unknown. In this study, we adopted adjuvant-induced arthritis (AA) murine model to explore the effect of tetrandrine on RA and neutrophils. Twenty-eight mice were divided into four groups. The control group was injected with PBS in the limbs and treated with PBS by intraperitoneal injection (i.p.) from Day 10 to Day 37. The arthritis murine model was induced by injecting FCA into the ankle joints of hind limbs. The AA group, the AA + TET group, and the AA + DEX group mice were treated with PBS, tetrandrine (6 mg/kg), or dexamethasone (1 mg/kg) i.p. daily, respectively. Arthritic scores were evaluated, and the joint diameter was measured every three days. A cytometric bead assay was performed to measure the concentrations of IFN-γ, TNF-α, and IL-6 in the serum. H&E staining and Safranin O-fast staining were adopted to monitor the tissue changes in the joint. Immunohistochemistry assays were applied to detect the MPO, NE, CitH3, and PAD4 expression levels. To assess the effect of tetrandrine on neutrophil activities in vitro, CCK8 tests were applied to determine cell viability. The qPCR and ELISA were performed to determine IL-1β and IL-6 expression levels. Immunofluorescence assays were performed to measure the formation of NETs. The results indicated that tetrandrine significantly alleviated the symptoms of RA in terms of the ankle diameter (from 4.629 ± 2.729 to 3.957 ± 0.257; P |
| doi_str_mv | 10.1155/2022/8589121 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8865980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2633565149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3631-4a7e953c76a3021150bda69a07c3d14030e4ca0ffa2e65f0572c7aef9345b26d3</originalsourceid><addsrcrecordid>eNp9kd1rFDEUxYMo9kPffJaAL4LdNh-TZOZFGIqtQq0gFexTyGbudFJmkm2SWel_b5Zdl-qDT_fC_XHuPfcg9IaSU0qFOGOEsbNa1A1l9Bk6pKqii4rV9fN9r34eoKOU7glhjVLqJTrggjEmlThEtzeQo_FddB5wO8HoQjQZEv4-wDyZHFyH25iH6LJL2Hn81VnAy0fcjiOsncnO3-FrmHMMq8GNuLXZrQsL6RV60ZsxwetdPUY_Lj7dnH9eXH27_HLeXi0sl7ycZxQ0glslDSesOCLLzsjGEGV5RyvCCVTWkL43DKToiVDMKgN9wyuxZLLjx-jjVnc1LyfoLPhiaNSr6CYTH3UwTv898W7Qd2Gt61qKpiZF4P1OIIaHGVLWk0sWxtF4CHPSTJZVtPxrg777B70Pc_TF3obiQgpaNYU62VI2hpQi9PtjKNGbzPQmM73LrOBvnxrYw39CKsCHLTA435lf7v9yvwG3xZ84</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2633565149</pqid></control><display><type>article</type><title>Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities</title><source>Wiley-Blackwell Open Access Titles</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Lu, Qingyi ; Jiang, Haixu ; Zhu, Qingqing ; Xu, Jie ; Cai, Yanan ; Huo, Guiyang ; Yuan, Kai ; Huang, Guangrui ; Xu, Anlong</creator><contributor>Shabbir, Arham ; Arham Shabbir</contributor><creatorcontrib>Lu, Qingyi ; Jiang, Haixu ; Zhu, Qingqing ; Xu, Jie ; Cai, Yanan ; Huo, Guiyang ; Yuan, Kai ; Huang, Guangrui ; Xu, Anlong ; Shabbir, Arham ; Arham Shabbir</creatorcontrib><description><![CDATA[Rheumatoid arthritis (RA) is a common autoimmune disease worldwide. Neutrophils play critical roles in the onset and development of RA and are the promising target for RA treatment. Tetrandrine is a bis-benzyl isoquinoline alkaloid derived from the traditional Chinese herbal Stephania tetrandra S. Moore. Tetrandrine is effective in alleviating RA by inhibiting macrophage inflammatory response, fibroblast overproliferation, and pannus formation. However, whether tetrandrine regulates the activities of neutrophils in RA is largely unknown. In this study, we adopted adjuvant-induced arthritis (AA) murine model to explore the effect of tetrandrine on RA and neutrophils. Twenty-eight mice were divided into four groups. The control group was injected with PBS in the limbs and treated with PBS by intraperitoneal injection (i.p.) from Day 10 to Day 37. The arthritis murine model was induced by injecting FCA into the ankle joints of hind limbs. The AA group, the AA + TET group, and the AA + DEX group mice were treated with PBS, tetrandrine (6 mg/kg), or dexamethasone (1 mg/kg) i.p. daily, respectively. Arthritic scores were evaluated, and the joint diameter was measured every three days. A cytometric bead assay was performed to measure the concentrations of IFN-γ, TNF-α, and IL-6 in the serum. H&E staining and Safranin O-fast staining were adopted to monitor the tissue changes in the joint. Immunohistochemistry assays were applied to detect the MPO, NE, CitH3, and PAD4 expression levels. To assess the effect of tetrandrine on neutrophil activities in vitro, CCK8 tests were applied to determine cell viability. The qPCR and ELISA were performed to determine IL-1β and IL-6 expression levels. Immunofluorescence assays were performed to measure the formation of NETs. The results indicated that tetrandrine significantly alleviated the symptoms of RA in terms of the ankle diameter (from 4.629 ± 2.729 to 3.957 ± 0.257; P<0.01) and ankle score (from 4.000 ± 0.000 to 3.286 ± 0.756; P<0.05). Tetrandrine treatment significantly increased the cartilage areas and decreased serum IL-6 significantly (from 5.954 ± 2.127 to 2.882 ± 2.013; P<0.01). The immunohistochemistry assays also showed decreased expression levels of NE, MPO, PAD4, and CitH3 induced by tetrandrine in comparison with the AA group (P<0.01). The qPCR assays and ELISAs showed that tetrandrine had an anti-inflammatory effect in vitro by significantly inhibiting IL-6 (P<0.01). The immunofluorescence assays showed that NET formation induced by PMA could be reduced by tetrandrine (P<0.01). In conclusion, tetrandrine has good efficacy in treating RA by regulating neutrophil-involved inflammation and NET formation.]]></description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2022/8589121</identifier><identifier>PMID: 35222675</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Animal models ; Ankle ; Antibodies ; Autoimmune diseases ; Cartilage ; Cell viability ; Chinese medicine ; Dexamethasone ; Disease ; Enzyme-linked immunosorbent assay ; Herbal medicine ; IL-1β ; Immunofluorescence ; Immunohistochemistry ; Inflammation ; Interleukin 6 ; Joint diseases ; Laboratory animals ; Leukocytes (neutrophilic) ; Limbs ; Macrophages ; Neutrophils ; Proteins ; Rheumatoid arthritis ; Steroids ; Tumor necrosis factor-α ; γ-Interferon</subject><ispartof>Evidence-based complementary and alternative medicine, 2022, Vol.2022, p.8589121-13</ispartof><rights>Copyright © 2022 Qingyi Lu et al.</rights><rights>Copyright © 2022 Qingyi Lu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Qingyi Lu et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3631-4a7e953c76a3021150bda69a07c3d14030e4ca0ffa2e65f0572c7aef9345b26d3</citedby><cites>FETCH-LOGICAL-c3631-4a7e953c76a3021150bda69a07c3d14030e4ca0ffa2e65f0572c7aef9345b26d3</cites><orcidid>0000-0003-1846-0227 ; 0000-0003-2925-6547 ; 0000-0002-0679-5284 ; 0000-0002-2948-3507 ; 0000-0003-0738-8725 ; 0000-0001-7239-449X ; 0000-0002-1131-4959 ; 0000-0002-4510-7042 ; 0000-0001-5344-7648</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865980/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865980/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35222675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Shabbir, Arham</contributor><contributor>Arham Shabbir</contributor><creatorcontrib>Lu, Qingyi</creatorcontrib><creatorcontrib>Jiang, Haixu</creatorcontrib><creatorcontrib>Zhu, Qingqing</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Cai, Yanan</creatorcontrib><creatorcontrib>Huo, Guiyang</creatorcontrib><creatorcontrib>Yuan, Kai</creatorcontrib><creatorcontrib>Huang, Guangrui</creatorcontrib><creatorcontrib>Xu, Anlong</creatorcontrib><title>Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description><![CDATA[Rheumatoid arthritis (RA) is a common autoimmune disease worldwide. Neutrophils play critical roles in the onset and development of RA and are the promising target for RA treatment. Tetrandrine is a bis-benzyl isoquinoline alkaloid derived from the traditional Chinese herbal Stephania tetrandra S. Moore. Tetrandrine is effective in alleviating RA by inhibiting macrophage inflammatory response, fibroblast overproliferation, and pannus formation. However, whether tetrandrine regulates the activities of neutrophils in RA is largely unknown. In this study, we adopted adjuvant-induced arthritis (AA) murine model to explore the effect of tetrandrine on RA and neutrophils. Twenty-eight mice were divided into four groups. The control group was injected with PBS in the limbs and treated with PBS by intraperitoneal injection (i.p.) from Day 10 to Day 37. The arthritis murine model was induced by injecting FCA into the ankle joints of hind limbs. The AA group, the AA + TET group, and the AA + DEX group mice were treated with PBS, tetrandrine (6 mg/kg), or dexamethasone (1 mg/kg) i.p. daily, respectively. Arthritic scores were evaluated, and the joint diameter was measured every three days. A cytometric bead assay was performed to measure the concentrations of IFN-γ, TNF-α, and IL-6 in the serum. H&E staining and Safranin O-fast staining were adopted to monitor the tissue changes in the joint. Immunohistochemistry assays were applied to detect the MPO, NE, CitH3, and PAD4 expression levels. To assess the effect of tetrandrine on neutrophil activities in vitro, CCK8 tests were applied to determine cell viability. The qPCR and ELISA were performed to determine IL-1β and IL-6 expression levels. Immunofluorescence assays were performed to measure the formation of NETs. The results indicated that tetrandrine significantly alleviated the symptoms of RA in terms of the ankle diameter (from 4.629 ± 2.729 to 3.957 ± 0.257; P<0.01) and ankle score (from 4.000 ± 0.000 to 3.286 ± 0.756; P<0.05). Tetrandrine treatment significantly increased the cartilage areas and decreased serum IL-6 significantly (from 5.954 ± 2.127 to 2.882 ± 2.013; P<0.01). The immunohistochemistry assays also showed decreased expression levels of NE, MPO, PAD4, and CitH3 induced by tetrandrine in comparison with the AA group (P<0.01). The qPCR assays and ELISAs showed that tetrandrine had an anti-inflammatory effect in vitro by significantly inhibiting IL-6 (P<0.01). The immunofluorescence assays showed that NET formation induced by PMA could be reduced by tetrandrine (P<0.01). In conclusion, tetrandrine has good efficacy in treating RA by regulating neutrophil-involved inflammation and NET formation.]]></description><subject>Animal models</subject><subject>Ankle</subject><subject>Antibodies</subject><subject>Autoimmune diseases</subject><subject>Cartilage</subject><subject>Cell viability</subject><subject>Chinese medicine</subject><subject>Dexamethasone</subject><subject>Disease</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Herbal medicine</subject><subject>IL-1β</subject><subject>Immunofluorescence</subject><subject>Immunohistochemistry</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Joint diseases</subject><subject>Laboratory animals</subject><subject>Leukocytes (neutrophilic)</subject><subject>Limbs</subject><subject>Macrophages</subject><subject>Neutrophils</subject><subject>Proteins</subject><subject>Rheumatoid arthritis</subject><subject>Steroids</subject><subject>Tumor necrosis factor-α</subject><subject>γ-Interferon</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kd1rFDEUxYMo9kPffJaAL4LdNh-TZOZFGIqtQq0gFexTyGbudFJmkm2SWel_b5Zdl-qDT_fC_XHuPfcg9IaSU0qFOGOEsbNa1A1l9Bk6pKqii4rV9fN9r34eoKOU7glhjVLqJTrggjEmlThEtzeQo_FddB5wO8HoQjQZEv4-wDyZHFyH25iH6LJL2Hn81VnAy0fcjiOsncnO3-FrmHMMq8GNuLXZrQsL6RV60ZsxwetdPUY_Lj7dnH9eXH27_HLeXi0sl7ycZxQ0glslDSesOCLLzsjGEGV5RyvCCVTWkL43DKToiVDMKgN9wyuxZLLjx-jjVnc1LyfoLPhiaNSr6CYTH3UwTv898W7Qd2Gt61qKpiZF4P1OIIaHGVLWk0sWxtF4CHPSTJZVtPxrg777B70Pc_TF3obiQgpaNYU62VI2hpQi9PtjKNGbzPQmM73LrOBvnxrYw39CKsCHLTA435lf7v9yvwG3xZ84</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Lu, Qingyi</creator><creator>Jiang, Haixu</creator><creator>Zhu, Qingqing</creator><creator>Xu, Jie</creator><creator>Cai, Yanan</creator><creator>Huo, Guiyang</creator><creator>Yuan, Kai</creator><creator>Huang, Guangrui</creator><creator>Xu, Anlong</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1846-0227</orcidid><orcidid>https://orcid.org/0000-0003-2925-6547</orcidid><orcidid>https://orcid.org/0000-0002-0679-5284</orcidid><orcidid>https://orcid.org/0000-0002-2948-3507</orcidid><orcidid>https://orcid.org/0000-0003-0738-8725</orcidid><orcidid>https://orcid.org/0000-0001-7239-449X</orcidid><orcidid>https://orcid.org/0000-0002-1131-4959</orcidid><orcidid>https://orcid.org/0000-0002-4510-7042</orcidid><orcidid>https://orcid.org/0000-0001-5344-7648</orcidid></search><sort><creationdate>2022</creationdate><title>Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities</title><author>Lu, Qingyi ; Jiang, Haixu ; Zhu, Qingqing ; Xu, Jie ; Cai, Yanan ; Huo, Guiyang ; Yuan, Kai ; Huang, Guangrui ; Xu, Anlong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3631-4a7e953c76a3021150bda69a07c3d14030e4ca0ffa2e65f0572c7aef9345b26d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animal models</topic><topic>Ankle</topic><topic>Antibodies</topic><topic>Autoimmune diseases</topic><topic>Cartilage</topic><topic>Cell viability</topic><topic>Chinese medicine</topic><topic>Dexamethasone</topic><topic>Disease</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Herbal medicine</topic><topic>IL-1β</topic><topic>Immunofluorescence</topic><topic>Immunohistochemistry</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Joint diseases</topic><topic>Laboratory animals</topic><topic>Leukocytes (neutrophilic)</topic><topic>Limbs</topic><topic>Macrophages</topic><topic>Neutrophils</topic><topic>Proteins</topic><topic>Rheumatoid arthritis</topic><topic>Steroids</topic><topic>Tumor necrosis factor-α</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Qingyi</creatorcontrib><creatorcontrib>Jiang, Haixu</creatorcontrib><creatorcontrib>Zhu, Qingqing</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Cai, Yanan</creatorcontrib><creatorcontrib>Huo, Guiyang</creatorcontrib><creatorcontrib>Yuan, Kai</creatorcontrib><creatorcontrib>Huang, Guangrui</creatorcontrib><creatorcontrib>Xu, Anlong</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Qingyi</au><au>Jiang, Haixu</au><au>Zhu, Qingqing</au><au>Xu, Jie</au><au>Cai, Yanan</au><au>Huo, Guiyang</au><au>Yuan, Kai</au><au>Huang, Guangrui</au><au>Xu, Anlong</au><au>Shabbir, Arham</au><au>Arham Shabbir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2022</date><risdate>2022</risdate><volume>2022</volume><spage>8589121</spage><epage>13</epage><pages>8589121-13</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract><![CDATA[Rheumatoid arthritis (RA) is a common autoimmune disease worldwide. Neutrophils play critical roles in the onset and development of RA and are the promising target for RA treatment. Tetrandrine is a bis-benzyl isoquinoline alkaloid derived from the traditional Chinese herbal Stephania tetrandra S. Moore. Tetrandrine is effective in alleviating RA by inhibiting macrophage inflammatory response, fibroblast overproliferation, and pannus formation. However, whether tetrandrine regulates the activities of neutrophils in RA is largely unknown. In this study, we adopted adjuvant-induced arthritis (AA) murine model to explore the effect of tetrandrine on RA and neutrophils. Twenty-eight mice were divided into four groups. The control group was injected with PBS in the limbs and treated with PBS by intraperitoneal injection (i.p.) from Day 10 to Day 37. The arthritis murine model was induced by injecting FCA into the ankle joints of hind limbs. The AA group, the AA + TET group, and the AA + DEX group mice were treated with PBS, tetrandrine (6 mg/kg), or dexamethasone (1 mg/kg) i.p. daily, respectively. Arthritic scores were evaluated, and the joint diameter was measured every three days. A cytometric bead assay was performed to measure the concentrations of IFN-γ, TNF-α, and IL-6 in the serum. H&E staining and Safranin O-fast staining were adopted to monitor the tissue changes in the joint. Immunohistochemistry assays were applied to detect the MPO, NE, CitH3, and PAD4 expression levels. To assess the effect of tetrandrine on neutrophil activities in vitro, CCK8 tests were applied to determine cell viability. The qPCR and ELISA were performed to determine IL-1β and IL-6 expression levels. Immunofluorescence assays were performed to measure the formation of NETs. The results indicated that tetrandrine significantly alleviated the symptoms of RA in terms of the ankle diameter (from 4.629 ± 2.729 to 3.957 ± 0.257; P<0.01) and ankle score (from 4.000 ± 0.000 to 3.286 ± 0.756; P<0.05). Tetrandrine treatment significantly increased the cartilage areas and decreased serum IL-6 significantly (from 5.954 ± 2.127 to 2.882 ± 2.013; P<0.01). The immunohistochemistry assays also showed decreased expression levels of NE, MPO, PAD4, and CitH3 induced by tetrandrine in comparison with the AA group (P<0.01). The qPCR assays and ELISAs showed that tetrandrine had an anti-inflammatory effect in vitro by significantly inhibiting IL-6 (P<0.01). The immunofluorescence assays showed that NET formation induced by PMA could be reduced by tetrandrine (P<0.01). In conclusion, tetrandrine has good efficacy in treating RA by regulating neutrophil-involved inflammation and NET formation.]]></abstract><cop>United States</cop><pub>Hindawi</pub><pmid>35222675</pmid><doi>10.1155/2022/8589121</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-1846-0227</orcidid><orcidid>https://orcid.org/0000-0003-2925-6547</orcidid><orcidid>https://orcid.org/0000-0002-0679-5284</orcidid><orcidid>https://orcid.org/0000-0002-2948-3507</orcidid><orcidid>https://orcid.org/0000-0003-0738-8725</orcidid><orcidid>https://orcid.org/0000-0001-7239-449X</orcidid><orcidid>https://orcid.org/0000-0002-1131-4959</orcidid><orcidid>https://orcid.org/0000-0002-4510-7042</orcidid><orcidid>https://orcid.org/0000-0001-5344-7648</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1741-427X |
| ispartof | Evidence-based complementary and alternative medicine, 2022, Vol.2022, p.8589121-13 |
| issn | 1741-427X 1741-4288 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8865980 |
| source | Wiley-Blackwell Open Access Titles; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
| subjects | Animal models Ankle Antibodies Autoimmune diseases Cartilage Cell viability Chinese medicine Dexamethasone Disease Enzyme-linked immunosorbent assay Herbal medicine IL-1β Immunofluorescence Immunohistochemistry Inflammation Interleukin 6 Joint diseases Laboratory animals Leukocytes (neutrophilic) Limbs Macrophages Neutrophils Proteins Rheumatoid arthritis Steroids Tumor necrosis factor-α γ-Interferon |
| title | Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A55%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tetrandrine%20Ameliorates%20Rheumatoid%20Arthritis%20in%20Mice%20by%20Alleviating%20Neutrophil%20Activities&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Lu,%20Qingyi&rft.date=2022&rft.volume=2022&rft.spage=8589121&rft.epage=13&rft.pages=8589121-13&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2022/8589121&rft_dat=%3Cproquest_pubme%3E2633565149%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2633565149&rft_id=info:pmid/35222675&rfr_iscdi=true |